Atlas Trials

A Study of AZD8233 in Participants With Dyslipidemia.

Clinical trial NCT04823611 · COMPLETED

Trial details

NCT number
NCT04823611
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Dyslipidemia
Start date
2021-01-20
Primary completion
2022-09-10
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.